These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of pyrrolidone-pyroglutamic acid composition on blood flow in rat middle cerebral artery. Semkina GA; Matsievskii DD; Mirzoyan NR Bull Exp Biol Med; 2006 Jan; 141(1):51-2. PubMed ID: 16929963 [TBL] [Abstract][Full Text] [Related]
6. [Effects of an antiischemic drug combination and nimodipine on cerebral blood supply in a hemorrhagic stroke model in rats]. Mirzoian NR; Gan'shina TS; Kurdiumov IN; Bero RS Eksp Klin Farmakol; 2008; 71(2):17-20. PubMed ID: 18488901 [TBL] [Abstract][Full Text] [Related]
7. [Effect of pyrrolidone-2 on the cerebral circulation]. Mirzoian SA; Ordian MB; Balasanian MG Biull Eksp Biol Med; 1987 Jan; 103(1):64-5. PubMed ID: 3801653 [TBL] [Abstract][Full Text] [Related]
8. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats. Baldacci M; Catalani R; Bartoli C; Mura U Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788 [No Abstract] [Full Text] [Related]
9. [Experimental study of some pharmacodynamic properties of magnesium 2-pyrrolidone-5-carboxylate]. Binet P; Miocque M; Pechery C; Roux M; Rinjard P Therapie; 1976; 31(4):471-81. PubMed ID: 137552 [No Abstract] [Full Text] [Related]
10. [A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam]. Nasybullina NM; Gunar VI; Zherdev VP; Sariev AK; Kozlova GS; Mirzoian RS; Gan'shina TS; Karaev AL Eksp Klin Farmakol; 1997; 60(2):58-61. PubMed ID: 9206573 [TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of piracetam on cerebral circulation]. Akopian VP; Balian LS Farmakol Toksikol; 1987; 50(1):38-41. PubMed ID: 3556550 [TBL] [Abstract][Full Text] [Related]
12. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats. Felicioli R; Saracchi I; Flagiello AM; Bartoli C Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694 [TBL] [Abstract][Full Text] [Related]
13. [The central vascular and metabolic effects of pyroglutamic acid]. Mirzoian SA; Zalinian MG; Balasanian MG; Topchian AV Eksp Klin Farmakol; 1994; 57(1):22-4. PubMed ID: 8142856 [TBL] [Abstract][Full Text] [Related]
14. Studies on insulin-like substances in Korean red ginseng. Takaku T; Kameda K; Matsuura Y; Sekiya K; Okuda H Planta Med; 1990 Feb; 56(1):27-30. PubMed ID: 2192378 [TBL] [Abstract][Full Text] [Related]
15. Effects of pyroglutamic acid on corticostriatal glutamatergic transmission. Dusticier N; Kerkerian L; Errami M; Nieoullon A Neuropharmacology; 1985 Sep; 24(9):903-8. PubMed ID: 2997655 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatography with fluorimetric detection in biological tissues of the 4-bromomethyl-7-methoxycoumarin ester derivative of 5-pyrrolidone-2-carboxylic acid. Bousquet E; Romeo G; Giannola LI J Chromatogr; 1985 Nov; 344():325-31. PubMed ID: 4086554 [No Abstract] [Full Text] [Related]
18. Chemical method for identification of N-blocked group in pyroglutamic acid peptides. Gupta S; Sharma K; Narang CK; Mathur NK Indian J Biochem Biophys; 1984 Apr; 21(2):133-4. PubMed ID: 6490073 [No Abstract] [Full Text] [Related]
19. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L-pyroglutamate. Príborský J; Takayama K; Nagai T; Waitzová D; Elis J; Makino Y; Suzuki Y Pharm Weekbl Sci; 1988 Oct; 10(5):189-92. PubMed ID: 3060835 [TBL] [Abstract][Full Text] [Related]
20. [The effect of esafosfina on cerebral circulation in intact and ischemized rat brain]. Gan'shina TS; Aleksandrin VV; Mirzoian RS Eksp Klin Farmakol; 2004; 67(4):19-20. PubMed ID: 15500039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]